Log in to save to my catalogue

Nemaline myopathy: reclassification of previously reported variants according to ACMG guidelines, an...

Nemaline myopathy: reclassification of previously reported variants according to ACMG guidelines, an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10620380

Nemaline myopathy: reclassification of previously reported variants according to ACMG guidelines, and report of novel genetic variants

About this item

Full title

Nemaline myopathy: reclassification of previously reported variants according to ACMG guidelines, and report of novel genetic variants

Publisher

England: Nature Publishing Group

Journal title

European journal of human genetics : EJHG, 2023-11, Vol.31 (11), p.1237-1250

Language

English

Formats

Publication information

Publisher

England: Nature Publishing Group

More information

Scope and Contents

Contents

Nemaline myopathy (NM) is a heterogeneous genetic neuromuscular disorder characterized by rod bodies in muscle fibers resulting in multiple complications due to muscle weakness. NM patients and their families could benefit from genetic analysis for early diagnosis, carrier and prenatal testing; however, clinical classification of variants is subjec...

Alternative Titles

Full title

Nemaline myopathy: reclassification of previously reported variants according to ACMG guidelines, and report of novel genetic variants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10620380

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10620380

Other Identifiers

ISSN

1018-4813,1476-5438

E-ISSN

1476-5438

DOI

10.1038/s41431-023-01378-w

How to access this item